AWAmie Wilson

Amie Wilson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amie Wilson has a total of 173 co-authors. Here are the top co-authors by number of shared publications:

  • Arri Coomarasamy

    Tommy’s National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women’s Health Research; University of Birmingham; Birmingham UK

    8 shared publications
  • David Lissauer

    Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK

    7 shared publications
  • Christine MacArthur

    School of Health and Population Sciences, College of Medical & Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK

    5 shared publications
  • Chisale Mhango

    College of Medicine, Department of Obstetrics and Gynaecology, Blantyre, Malawi

    4 shared publications
  • Javier Zamora

    Ramon y Cajal Biomedical Research Institute (IRYCIS), Madrid, Spain; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain

    4 shared publications
  • Iffat Ahmed

    The Aga Khan University Hospital and Medical College Foundation, Karachi, Pakistan

    3 shared publications

Latest Publications

  • Open Access

    Interventions to support parents, families and caregivers in caring for preterm or low birth weight infants at home: A systematic review and meta-analysis

    by Amie Wilson, Carol Bedwell, Valentina Actis Danna, Natalie Tate, Kerry Dwan, Anayda Portela, Tina Lavender

    The aim of this study was to determine what interventions, approaches, or strategies to support mothers/fathers/caregivers and families in caring for preterm (<37 gestational weeks) or low birthweight (<2,500g) infants in the home have been effective in improving outcomes. We conducted a systematic review and meta-analysis. A comprehensive search of relevant electronic databases, including MEDLINE, Embase, CINAHL and Cochrane Central Register of Controlled Trials was completed in September 2024. Studies were included if they utilised interventions which focused on providing support to participants (mother/father/parents, families or caregivers) to care for their infants in the home. Two reviewers independently screened papers in Covidence and extracted data. Random effects meta-analyses were undertaken. Quality of studies and certainty of evidence were assessed using CASP and GRADE, respectively. Critical outcomes based on WHO preterm and low birthweight criteria comprised infant mortality, morbidity, growth and neurodevelopment. Priority outcomes comprised breastfeeding, care seeking, parent-infant interaction, mother-child attachment and parental health and wellbeing. Forty-seven studies were included. There is some evidence that support interventions may improve outcomes related to infant mortality, improvements in infant growth, exclusive breastfeeding, infant cognitive development, immunisation uptake, and reduction in maternal stress and depression. However, the overall certainty of evidence is low or very low in the majority of studies. We conclude that interventions providing support for parents to care for infants in the home may improve outcomes for this population. There is a need for well-considered large scale support interventions, prioritised and developed with women and families.


  • Open Access

    Associations between epileptic seizures in pregnancy and adverse pregnancy outcomes: A systematic review and meta-analysis

    by Oladipupo Olalere, Saba Tariq, Olanike Ajijola, Min-Dee Koh, Katie Crabb, Amie Wilson, Anwesa Chatterjee, Mairead Black, Katie Morris, Matthew Bluett-Duncan, et al.

    Background: Epileptic seizures during pregnancy may increase the risk of adverse pregnancy outcomes. Socioeconomic disparities in epilepsy incidence may extend to seizure control. We conducted a systematic review and meta-analysis to assess the association between epileptic seizures during pregnancy and adverse pregnancy outcomes. We also evaluated the association between socioeconomic and individual-level factors and seizure occurrence. Methods and findings: We searched MEDLINE, Embase, CINAHL, and PsycINFO databases from inception to May 2025 for observational studies on pregnant women with epileptic seizures. We compared maternal and foetal outcomes in pregnant women with and without seizures and assessed the association between seizure occurrence and socioeconomic or individual-level factors. We used the Newcastle–Ottawa Scale to assess the risk of bias of included studies. Meta-analyses using random effects model were performed to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs). From 13,381 identified publications, 25 studies (24,596 pregnancies) are included in this analysis. In pregnant women with epilepsy, women with seizures compared to those without had increased odds of caesarean birth (OR 1.62, 95% CI 1.14 to 2.30, p = 0.007), peripartum depression (OR 2.20, 95% CI 1.04 to 4.65, p = 0.04), and small for gestational age baby (OR 1.32, 95% CI 1.03 to 1.69, p = 0.03). The odds of preterm birth (OR 1.66, 95% CI 1.29 to 2.15, p < 0.001), low birthweight (OR 1.47, 95% CI 1.12 to 1.93, p = 0.006), and small for gestational age baby (OR 1.44, 95% CI 1.19 to 1.74, p < 0.001) were higher in women with seizures compared to women without epilepsy. The risk of seizures was greater in pregnant women with epilepsy with low income compared to those with higher income (OR 1.57, 95% CI 1.22 to 2.02, p < 0.001), and in women with focal epilepsy compared to those with generalised epilepsy (OR 1.84, 95% CI 1.54 to 2.20, p < 0.001). The number of studies for some outcomes was small, limiting subgroup analyses and detection of heterogeneity. Conclusion: Epileptic seizures are associated with increased risks of adverse maternal and foetal outcomes. Risk assessment to identify women with epilepsy at highest risk of seizures is needed to optimise care.


  • Open Access

    Variations in caesarean section outcome reporting in low- and middle-income countries: A systematic review

    by Amie Wilson, Harpreet Kaur, Ahmed Ali Hassan, Bernard Mbwele, Soha Sobhy, Gabriel Ruiz Calvo, Sergio Olmos Piñero, Javier Zamora, Shakila Thangaratinam


  • Open Access

    Midwives’ and maternity support workers’ perceptions of the impact of the first year of the COVID-19 pandemic on respectful maternity care in a diverse region of the UK: a qualitative study

    by Isobel H M Jones, Amy Thompson, Catherine Louise Dunlop, Amie Wilson

    Objectives To explore midwives’ and maternity support workers’ perceptions of the impact of the COVID-19 pandemic on maternity services and understand factors influencing respectful maternity care. Design A qualitative study. Eleven semistructured interviews were conducted (on Zoom) and thematically analysed. Inductive themes were developed and compared with components of respectful maternity care. Setting Maternity services in a diverse region of the United Kingdom. Participants Midwives and maternity support workers who worked during the first year of the COVID-19 pandemic. Results The findings offer insights into the experiences and challenges faced by midwives and maternity support workers during the first year of the COVID-19 pandemic in the UK (March 2020–2021). Three core themes were interpreted that impacted respectful maternity care: (1) communication of care, (2) clinical care and (3) support for families. 1. Midwives and maternity support workers felt changing guidance impaired communication of accurate information. However, women attending appointments alone encouraged safeguarding disclosures. 2. Maternity staffing pressures worsened and delayed care provision. The health service’s COVID-19 response was thought to have discouraged women’s engagement with maternity care. 3. Social support for women was reduced and overstretched staff struggled to fill this role. The continuity of carer model of midwifery facilitated supportive care. COVID-19 restrictions separated families and were considered detrimental to parents’ mental health and newborn bonding. Overall, comparison of interview quotes to components of respectful maternity care showed challenges during the early COVID-19 pandemic in upholding each of the 10 rights afforded to women and newborns. Conclusions Respectful maternity care was impacted through changes in communication, delivery of clinical care and restrictions on social support for women and their infants in the first year of the COVID-19 pandemic. Future guidance for pandemic scenarios must make careful consideration of women’s and newborns’ rights to respectful maternity care.


  • Prophylactic antibiotics for uterine evacuation procedures to treat miscarriage

    by Sheikh Irfan Ahmed, Anne Ammerdorffer, Catherine A Moakes, James Cheshire, Ahmet Metin Gülmezoglu, Arri Coomarasamy, David Lissauer, Amie Wilson

    Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The objective of this review is to evaluate the effectiveness of routine antibiotic prophylaxis to women undergoing uterine evacuation procedures to treat miscarriage.


  • Open Access

    The content and completeness of women-held maternity documents before admission for labour: A mixed methods study in Banjul, The Gambia

    by Lotta Gustafsson, Fides Lu, Faith Rickard, Christine MacArthur, Carole Cummins, Ivan Coker, Kebba Mane, Amie Wilson, Semira Manaseki-Holland

    Women-held maternity documents are well established for enabling continuity of maternity care worldwide, with the World Health Organisation (WHO) recommending their use in effective decision-making. We aimed to assess the presence, content and completeness of women-held maternity documents at admission to hospitals in The Gambia, and investigate barriers and facilitators to their completion. We interviewed 250 women on maternity wards of all 3 Banjul hospitals and conducted content analysis of documentation brought by women on admission for their completeness against WHO referrals criteria. Logistic regression models were used to estimate the odds of the minimum criteria being met. Two focus groups and 21 semi-structured interviews (8 doctors, 8 midwives and 5 nurses) were conducted with healthcare practitioners to explore barriers and facilitators to documented clinical information availability on admission. Of the women admitted, all but 10/250 (4%) brought either a maternity card or a structured referral sheet. Of all forms of documentation, women most frequently brought the government-issued maternity card (235/250, 94%); 16% of cards had all 9 minimum criteria completed. Of the 79 referred women, 60% carried standardised referral forms. Only 30% of 97 high-risk women had risk-status recorded. Women were less likely to have documents complete if they were illiterate, had not attended three maternity appointments, or lived more than one hour from hospital. During qualitative interviews, three themes were identified: women as agents for transporting information and documents (e.g. remembering to bring maternity cards); role of individual healthcare professionals’ actions (e.g. legibility of handwriting); system and organisational culture (e.g. standardised referral guidelines). Women rarely forgot their maternity card, but documents brought at admission were frequently incomplete. This is a missed opportunity to enhance handover and quality of care, especially for high-risk women. National guidelines were recognised by providers as needed for good document keeping and would enhance the women-held maternity documents’ contribution to improving both safety and continuity of care.


  • Vaginal preparation with chlorhexidine at cesarean section to reduce endometritis and prevent sepsis: A randomized pilot trial (PREPS)

    by Victoria Hodgetts-Morton, Catherine A. Hewitt, Amie Wilson, Nicola Farmer, Annalise Weckesser, Emily Dixon, Peter Brocklehurst, Pollyanna Hardy, Rachel K. Morris

    Introduction: Cesarean sections are the most common major operation worldwide. One in 10 women develops a surgical‐site infection after cesarean section. The PREPS pilot trial was developed to assess the feasibility of a randomized controlled trial of vaginal cleansing with chlorhexidine before cesarean section, to reduce infectious morbidity.Material and methods: A multi‐center, open‐label, parallel‐group pilot randomized controlled trial across 4 UK maternity units. Women aged ≥16 years, undergoing elective or emergency cesarean section, ≥34 weeks of gestation, and able to give informed consent were eligible. Women were randomized 1:1 to chlorhexidine 0.05% or no cleansing and were followed up until 6 weeks after cesarean section. The feasibility of a larger randomized controlled trial was assessed by the pilot trial’s recruitment, ability to use verbal consent in an emergency, adherence, follow‐up and withdrawal rates. The main clinical outcome collected was Center for Disease Control and Prevention (CDC) classification of endometritis at 30 days. Trial registration number is ISRCTN33435996.Results: A total of 320 women (128% of target) were randomized. Of these, 93% (95% CI 89%‐95%) received their allocated intervention. Of the 88 women who had an emergency cesarean section, verbal consent was initially given by 32 (36%) women, with the remainder having sufficient time to give written consent. Endometritis (CDC definition) was collected from medical notes of 96% of women, 68% (95% CI 63%‐73%) were followed up at both 14 and 30 days by telephone, and we were able to collect patient‐reported outcomes. In the vaginal cleansing arm 2/152 (1.3%) women had endometritis compared with 1/155 (0.7%) in the no cleansing arm (RR 2.08, 95% CI 0.19‐22.31).Conclusions: It is possible to perform a randomized controlled trial in women undergoing an elective or emergency cesarean section, using a verbal‐followed‐by‐written consent process, while maintaining high adherence and retaining women in the trial.


  • Open Access

    Antibiotic prophylaxis in the surgical management of miscarriage in low-income countries: a cost-effectiveness analysis of the AIMS trial

    by Ilias Goranitis, David M Lissauer, Arri Coomarasamy, Amie Wilson, Jane Daniels, Lee Middleton, Jonathan Bishop, Catherine A Hewitt, Andrew D Weeks, Chisale Mhango, et al.


  • Open Access

    Women’s perspectives on caesarean section recovery, infection and the PREPS trial: a qualitative pilot study

    by Annalise Weckesser, Nicola Farmer, Rinita Dam, Amie Wilson, Victoria Hodgetts Morton, R. Katie Morris

    In England, 27.8% of all pregnant women undergo caesarean sections (CS) to deliver their babies. Women undergoing CS are at risk of developing sepsis and post-natal infections, which not only contribute significantly to maternal mortality and morbidity, but also negatively impact upon post-natal recovery and wellbeing. This study explores patients’ priorities in relation to CS recovery, focusing on their knowledge and experiences of infection prevention. The study formed part of the PREPS (Vaginal Preparation at caesarean section to Reduce Endometritis and Prevent Sepsis – a feasibility study of chlorhexidine) Trial; patients’ views on the PREPS Trial were also sought. Using qualitative methodology, two focus groups and six telephone interviews were carried out between September and October 2017 with a total of 21 women who had undergone a CS within the preceding six months. Focus groups and individual telephone interviews were audio-recorded and transcribed verbatim; a thematic analysis was conducted using NVivo 11. Women’s priorities around CS recovery centred on pain (or the lack thereof), mobility and the ability to resume everyday activities, including caregiving. Those undergoing a CS for the first time reported not feeling confident in their ability to identify signs of infection and sought visiting health professionals’ expertise and reassurance. Women were unable to recall whether they had received information regarding infection prevention and felt that they had not received sufficient advice. Some reported receiving general information regarding CS recovery, which ranged in quality. Prevention of womb infection is a major goal of the PREPS trial, however, the majority of women were not aware that womb (as opposed to wound) infection was a post CS risk. Women undergoing a CS want more information on what constitutes a ‘normal’ post-operative recovery and specifically would welcome written information and infection prevention advice. This should be a key element of improving post-CS maternal experiences and potentially reducing sepsis and infection rates. CS stigma negatively impacts women’s recovery experiences and possibly information provision. The PREPS team incorporated findings regarding consent pathways for recruiting women into intrapartum research and developed two patient reported outcomes to collect in the main trial. The PREPS trial has been registered with ISRCTN on the 10th July 2017 ( ISRCTN33435996 ).


  • A Randomized Trial of Prophylactic Antibiotics for Miscarriage Surgery

    by David Lissauer, Amie Wilson, Catherine A. Hewitt, Lee Middleton, Jonathan R.B. Bishop, Jane Daniels, Abi Merriel, Andrew Weeks, Chisale Mhango, Ronald Mataya, et al.

    Surgical intervention is needed in some cases of spontaneous abortion to remove retained products of conception. Antibiotic prophylaxis may reduce the risk of pelvic infection, which is an important complication of this surgery, particularly in low-resource countries. We conducted a double-blind, placebo-controlled, randomized trial investigating whether antibiotic prophylaxis before surgery to complete a spontaneous abortion would reduce pelvic infection among women and adolescents in low-resource countries. We randomly assigned patients to a single preoperative dose of 400 mg of oral doxycycline and 400 mg of oral metronidazole or identical placebos. The primary outcome was pelvic infection within 14 days after surgery. Pelvic infection was defined by the presence of two or more of four clinical features (purulent vaginal discharge, pyrexia, uterine tenderness, and leukocytosis) or by the presence of one of these features and the clinically identified need to administer antibiotics. The definition of pelvic infection was changed before the unblinding of the data; the original strict definition was two or more of the clinical features, without reference to the administration of antibiotics. We enrolled 3412 patients in Malawi, Pakistan, Tanzania, and Uganda. A total of 1705 patients were assigned to receive antibiotics and 1707 to receive placebo. The risk of pelvic infection was 4.1% (68 of 1676 pregnancies) in the antibiotics group and 5.3% (90 of 1684 pregnancies) in the placebo group (risk ratio, 0.77; 95% confidence interval [CI], 0.56 to 1.04; P=0.09). Pelvic infection according to original strict criteria was diagnosed in 1.5% (26 of 1700 pregnancies) and 2.6% (44 of 1704 pregnancies), respectively (risk ratio, 0.60; 95% CI, 0.37 to 0.96). There were no significant between-group differences in adverse events. Antibiotic prophylaxis before miscarriage surgery did not result in a significantly lower risk of pelvic infection, as defined by pragmatic broad criteria, than placebo. (Funded by the Medical Research Council and others; AIMS Current Controlled Trials number, ISRCTN97143849.)